{
    "nct_id": "NCT06276946",
    "official_title": "Randomized Assessment of Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia Following Radiotherapy for Oropharynx Cancer",
    "inclusion_criteria": "In order to participate in this study a subject must meet all of the eligibility criteria outlined below. Eligibility must be maintained up for the subject to be considered eligible for treatment.\n\nInclusion Criteria\n\n1. Written informed consent was obtained to participate in the study and HIPAA authorization for the release of personal health information.\n2. Subjects is willing and able to comply with study procedures based on the judgment of the investigator.\n3. Age â‰¥ 18 years at the time of consent.\n4. T0-4, N0-3, M0 disease American Joint Committee on Cancer (AJCC 7th or 8th edition) of the oropharynx (this includes patients with head and neck cancer of unknown primary origin, often categorized as T0 disease, who will be treated with radiotherapy to the oropharynx) planned for definitive radiotherapy +/- chemotherapy\n\n5 No contraindications to receiving MRI such as implanted electrical devices, pregnancy, and significant quantities of metal in the head/neck\n\nExclusion Criteria\n\n1. Patients with Sjogren's syndrome or baseline xerostomia (CTCAE > 0 for the question regarding dry mouth)\n2. Patients with lesions grossly involving the salivary glands\n3. Patients with an allergy to lemon juice\n4. Prior history of radiation therapy to the head and neck\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}